The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions

Atherosclerosis

Volumn 131, Issue 2, 1997, Pages 177-186

  Cai, Wei Jun ^a,b   Devaux, Bruno ^a   Schaper, Wolfgang ^a   Schaper, Jutta ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Coronary arteries; Fas APO 1; Human atherosclerosis

Indexed keywords

APOLIPOPROTEIN; DNA FRAGMENT;

ADULT; APOPTOSIS; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENDOTHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DNA; DNA FRAGMENTATION; FEMALE; GENES, BCL-2; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; SPECTROPHOTOMETRY; TUNICA INTIMA;

EID: 0030956881     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)06099-1     Document Type: Article

References (43)

1. Arends M, Wyllie A. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991;32:223-254.
2. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 1992;11:95-103.
3. Waring P, Kos FJ, Müllbacher A. Apoptosis or programmed cell death. Med Res Rev 1991;11:219-236.
4. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD. Programmed cell death and the the control of cell survival: lessons from the nervous system. Science 1993;262:695-700.
5. James TN. Normal and abnormal consequences of apoptosis in the human heart from postnatal morphogenesis to paroxysmal arrhythmias. Circulation 1994;90:556-573.
6. Martin SJ. Apoptosis: suicide, execution or murder? Trends Cell Biol 1993;3:141-144.
7. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 1995;146:3-15.
8. Roos R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1993;362:801-809.
9. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages and SMCs in the human atherosclerotic plaque. Atherosclerosis 1986;6:131-138.
10. Velican D. Intima thickening in developing coronary arteries and its relevance to atherosclerotic involvement. Atherosclerosis 1976;23:345-355.
11. Gerrity RG. The role of the monocyte in atherogenesis: I transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981;103:181-190.
12. Rekhter MD, Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol 1995;147:668-677.
13. Garratt KN, Edwards WD, Kaufmann UP, Vlietstra RE, Holmes DRJ. Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and sapherous vein bypass graft: analysis of tissue obtained from 73 patients by directional atherectomy. J Am Coll Cardiol 1991;17:442-448.
14. Han DKM, Haudenschild CC, Hong MK, Tinke BT, Leon MB, Lian G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995;147:267-277.
15. Geng YJ, Libby P. Evidence for apoptosis in advanced atheroma - colocalization with interleukin-1ß-converting enzyme. Am J Pathol 1995;147:251-266.
16. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995;91:2703-2711.
17. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaque. J Clin Invest 1995;95:2266-2274.
18. Cho A, Courtman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res 1995;76:168-175.
19. Guidotti GG, Urbani S, Alfieri R. Genetic control of apoptosis. Fundam Clin Immunol 1995;3:56-58.
20. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
21. Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
22. Oehm A, Behrmamn I, Falk W et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J Biol Chem 1992;267:10 709-10 715.
23. Watanabe R, Brannan CI, Itoh N et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-1279.
24. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994;179:873-879.
25. Oishi M, Maeda K, Sugiyamas S. Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines. Arch Dermatol Res 1994;286:396-407.
26. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-1455.
27. Schulze-Osthoff K. The Fas/APO-1 receptor and its deadly ligand. Trends Cell Biol 1994;4:421-426.
28. Stary HC, Chandler AB, Dinsmore RE et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation 1995;92:1355-1374.
29. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
30. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397-400.
31. Boudreau N, Sympson CJ, Werb Z, Bissel MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995;267:891-893.
32. Klagsbrun M, Edelman ER. Biological and biochemical properties of fibroblast growth factors: implication for the pathogenesis of atherosclerosis. Arteriosclerosis 1989;9:269-278.
33. Ross R, Masuda J, Raines EW et al. Localization of PDGF-B protein in macrophages in all phases of atherosclerosis. Science 1990;248:1009-1012.
34. Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988;82:1134-1143.
35. Schwartz SM, Bennett MR. Death by any other name. Am J Pathol 1995;147:229-234.
36. Dong C, Wilson JE, Winters GL, McManus BM. Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest 1996;74:921-931.
37. Liu Y, Cigola E, Cheng W et al. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 1995;73:771-787.
38. Tanaka M, Ito H, Adachi S et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75:426-433.
39. Gonschior P, Nerlich A, Mack B, Wiest IRM, Hofling B. Immunohistochemical differentiation of arteriosclerotic intimal tissue specimen from primary and restenoses. Vasa-J Vas Dis 1994;23:15-22.
40. Dhein J, Walczak H, Baümler C, Debatin K-M, Krammer PH. Autocrine T-cells suicide mediated by APO-1/(Fas/CD95). Nature 1995;373:438-441.
41. Ju S-T, Panka DJ, Cui H et al. Fas (CD95)/Fas L interactions required for programmed cell death after T-cell activation. Nature 1995;373:444-448.
42. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
43. Kockx MM, Cambier BA, Bortier HE et al. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts. Histology 1994;25:365-371.